title: Schistosoma mansoni soluble egg antigens enhance T cell responses to a newly identified HIV-1 Gag H-2b epitope.
abstract: Schistosome infection induces significant T helper type 2 (Th2) and anti-inflammatory immune responses and has been shown to negatively impact vaccine efficacy. Our goal was to determine if the administration of schistosome soluble egg antigens (SEA) would negatively influence the induction of cytotoxic T lymphocyte (CTL) and Th1-type T cell responses to an HIV candidate vaccine in the Th1-biased C57BL/6 mouse strain. Initial experiments failed, as we were unable to detect any response to the defined class I epitope for HIV-1 IIIB Gag. Therefore, we initiated an epitope mapping study to identify C57BL/6 (H-2(b)) T cell epitopes in HIV-1 IIIB Gag in order to perform the experiments. This analysis defined two previously unreported minimal class I H-2(b) and class II I-A(b) epitopes for HIV-1 IIIB Gag. The newly defined HIV-1 IIIB Gag epitopes were used to evaluate the influence of SEA on the generation of CTL and Th1-type HIV-1 IIIB Gag responses. Surprisingly, in contrast to our hypothesis, we observed that the coadministration of SEA with a Listeria monocytogenes vector expressing HIV-1 IIIB Gag (Lm-Gag) led to a significantly increased frequency of gamma interferon (IFN-γ)-producing CD8(+) and CD4(+) T cells in C57BL/6 mice compared to mice immunized with Lm-Gag only. These observations suggest that SEA contains, in addition to Th2-type and immune-suppressive molecules, substances that can act with the Lm-Gag vaccine to increase CTL and Th1-type vaccine-specific immune responses.
authors.affiliation: Department of Infectious Diseases, University of Georgia, Athens, Georgia, USA Center for Tropical and Emerging Global Diseases, University of Georgia, Athens, Georgia, USA.
authors.forename: Cac T
authors.initials: CT
authors.lastname: Bui
authors.affiliation: Department of Infectious Diseases, University of Georgia, Athens, Georgia, USA Center for Tropical and Emerging Global Diseases, University of Georgia, Athens, Georgia, USA.
authors.forename: Lisa M
authors.initials: LM
authors.lastname: Shollenberger
authors.affiliation: Department of Microbiology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
authors.forename: Yvonne
authors.initials: Y
authors.lastname: Paterson
authors.affiliation: Department of Infectious Diseases, University of Georgia, Athens, Georgia, USA Center for Tropical and Emerging Global Diseases, University of Georgia, Athens, Georgia, USA dharn@uga.edu.
authors.forename: Donald A
authors.initials: DA
authors.lastname: Harn
mesh_terms: D016915:AIDS Vaccines / Q000008:administration & dosage / Q000276:immunology*; D000818:Animals; D000947:Antigens, Helminth / Q000276:immunology*; D018984:Epitopes, T-Lymphocyte / Q000276:immunology*; D005260:Female; D015497:HIV-1 / Q000276:immunology*; D007371:Interferon-gamma / Q000378:metabolism; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D012550:Schistosoma mansoni / Q000276:immunology*; D013601:T-Lymphocytes / Q000276:immunology*; D054301:gag Gene Products, Human Immunodeficiency Virus / Q000276:immunology*
chemical_list: D016915:AIDS Vaccines; D000947:Antigens, Helminth; D018984:Epitopes, T-Lymphocyte; D054301:gag Gene Products, Human Immunodeficiency Virus; D007371:Interferon-gamma